Biomarkers for the experimental therapeutics of Huntington's disease (HD) and Parkinson's disease (PD)

被引：0
|
作者：
Shoulson, I [1 ]
机构：
[1] Univ Rochester, Rochester, NY 14620 USA
来源：
BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS | 2000年 / 1205卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：47 / 49
页数：3
相关论文
共 50 条
  • [21] Emerging therapeutics in Huntington's disease
    Wiggins, Robert
    Feigin, Andrew
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (03) : 295 - 302
  • [22] Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
    Francardo, Veronica
    Schmitz, Yvonne
    Sulzer, David
    Cenci, M. Angela
    EXPERIMENTAL NEUROLOGY, 2017, 298 : 137 - 147
  • [23] Neurodegenerative disorders: Parkinson's disease and Huntington's disease
    Hague, SM
    Klaffke, S
    Bandmann, O
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (08): : 1058 - 1063
  • [24] Verb processing in Parkinson's disease and Huntington's disease
    Peran, P.
    Goutines, E.
    Demonet, J. F.
    Rascol, O.
    Cardebat, D.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 282 - 283
  • [25] Parkinson's disease and Huntington's disease by PET and MRI
    Piccini, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 21 - 22
  • [26] Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics
    Perez-Arancibia, Rodrigo
    Cisternas-Olmedo, Marisol
    Sepulveda, Denisse
    Troncoso-Escudero, Paulina
    Vidal, Rene L.
    FRONTIERS IN NEUROSCIENCE, 2023, 16
  • [27] Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?
    Bates, GP
    Hockly, E
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (04) : 465 - 470
  • [28] Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
    Hoekstra, Jake G.
    Montine, Kathleen S.
    Zhang, Jing
    Montine, Thomas J.
    ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (03):
  • [29] Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
    Jake G Hoekstra
    Kathleen S Montine
    Jing Zhang
    Thomas J Montine
    Alzheimer's Research & Therapy, 3
  • [30] Biomarkers for Alzheimer's disease and Parkinson's disease
    Growdon, John H.
    Irizarry, Michael C.
    Scherzer, Clemens
    ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES, 2008, 57 : 169 - 174
12345